You are here: Industry Insights > Omicron

News List

Immune Biosolutions Lead Immunotherapy Neutralizes SARS-CoV-2 Variants contractpharma
January 10, 2022
IBIO123 is an inhaled antibody-based immunotherapy in phase 1 and 2 clinical development for the treatment of symptomatic SARS-CoV-2.
Covid-19 update: Pfizer expects under 5’s vaccination trial data by April Pharmaceutical-Technology
January 07, 2022
Global: The global Covid-19 death toll has passed 5.4 million, with a figure of 5,465,542 according to researchers at Johns Hopkins University. Meanwhile, infections passed 297 million world wide.
Moderna CEO Says Fourth COVID-19 Dose May Be Needed Next Fall drugs
January 07, 2022
A fourth COVID-19 vaccine may be needed for most people by next fall because of what will likely be waning immunity, Moderna CEO Stephane Bancel said Thursday.
Some At-Home Tests May Miss Omicron in Early Stages of Infection drugs
January 06, 2022
The Abbott BinaxNOW and Quidel QuickVue -- two widely used rapid at-home COVID-19 tests -- may sometimes fail to spot evidence of the omicron variant in the first days after infection, even when people are carrying substantial levels of the virus, prelimi
AstraZeneca and Novavax say their vaccines are effective against Omicron pharmatimes
January 05, 2022
WHO officials remain cautious about claiming Omicron as a milder variant of the COVID-19 virus.
Over 90 care home operators in England declare red alert over staff shortages pharmatimes
January 05, 2022
Pressure on care and NHS staff mounts with the spread of the latest Omicron variant of COVID-19.
Breakthrough Discoveries on Novel Features of Omicron Variant and An Anti-Omicron Antibody JMB2002 prnasia
January 04, 2022
Joint research results from Biologics of Jemincare and Shanghai Institute of Materia Medica (SIMM) of Chinese Academy of Sciences (CAS) confirmed that JMB2002...
Why we need an Aatmanirbhar booster strategy ExpressPharma
January 04, 2022
A year ago, I asked if intellectual property rights (IPRs) could be part of the COVID-19 solution, rather than the problem.
UK life sciences trade group calls for oral Covid-19 antiviral investment Pharmaceutical-Technology
January 04, 2022
The UK government must invest in Covid-19 antiviral treatments like it did with vaccines, said the chair of the UK BioIndustry Association.
Scientists Spot Clues to Why Omicron Infections Are Milder drugs
January 03, 2022
New animal research offers a compelling explanation as to how the omicron variant causes less severe disease than some of its predecessors: It seems to settle in the nose, throat, and windpipe, rather than traveling down to the lungs.

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page